Q301--Veracyte Decipher Prostate Testing (VA-26-00004393) FY26 Base Plus 4 Option Years
Closed Special Notice Posted
- Solicitation number
- 36C24226Q0004
- Agency
-
Veterans Integrated Service Network 2
Veterans Health Administration, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 has published a Special Notice of Intent to Sole Source for Veracyte Decipher Prostate Testing services at the Northport VAMC Healthcare System in New York. The VA intends to award a sole source contract to Veracyte Labs SD Corp under FAR Part 6.302-1 for a base period plus four option years, with an estimated value of $36.5 million. This firm fixed-price contract will provide specialized prostate cancer diagnostic testing services using the Decipher Prostate test, which is a tissue-based gene expression test that utilizes whole-transcriptome microarray technology to assess tumor biology. The test is recommended by the National Comprehensive Cancer Network and helps physicians determine the likelihood of cancer metastasis within five to ten years, enabling personalized treatment plans for patients.
The primary purpose of this Special Notice is to conduct market research and identify potential qualified small businesses, particularly Service-Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HubZone, and other small businesses capable of providing these specialized laboratory testing services. Interested contractors must respond via email to Lorraine.Hussain@va.gov within 14 calendar days of the notice publication date of August 4, 2025, making the deadline August 18, 2025. All potential offerors must be registered in the System for Award Management (SAM.gov) with completed Representations and Certifications, and must provide detailed documentation of their technical expertise, business information, and capability to deliver the required services. The notice operates under NAICS code 621511 (Medical Laboratories) and emphasizes that no funds have been authorized for this effort, with the government having no obligation to pay for response costs or guarantee contract award based on this market research activity.
Notice text
Notice Type:
Special Notice of Intent to Sole Source
This is a SPECIAL NOTICE ANNOUNCEMENT ONLY. The Department of Veteran Affairs, VISN 2 Network Contracting Office, intends to award a sole source contract for the Northport New York HCS. This proposed contract action is for a service in which the Government intends to award a Base Period plus four (4) Option Periods, firm fixed-price contract with only one source; Veracyte Labs SD Corp, 6925 Lusk Blvd Ste 200, San Diego, CA 92121, Suite 200, under the authority Federal Acquisition Regulation (FAR) Part 6.302-1 Only One Responsible Source.
Places of Performance:
Department of Veterans Affairs
Northport VAMC Healthcare System
Northport VAMC
79 Middleville Rd
Northport, NY 11768
Purpose and Objectives:
The intent of this Special Notice is to identify potential offerors capable of providing the Veracyte Decipher Prostrate Services for Northport VAMC, New York.
General Requirements
Northport VAMC Department of Pathology and Laboratory Medicine Services has a need to acquire Veracyte, Inc. Decipher Prostate testing services. Decipher Prostate test is a tissue-based gene expression test utilizing whole-transcriptome microarray technology to assess the underlying biology of a patient s tumor. This test is performed on prostate tumor tissue from biopsy or radical prostatectomy. The Decipher Prostate is recommended in the NCCN Guidelines (National Comprehensive Cancer Network), and the test is used to determine how likely the patient s cancer is to metastasize within the next five years and ten years. Based on the results, the physician may recommend less intensive treatment or earlier, more intensive treatment. The Decipher Prostate test is designed to give physicians and their patients clarity and confidence in developing a personalized treatment plan.
The contractor shall provide laboratory testing services to include specimen requirements and means of transport for specimens from patient to the contractor s laboratory; processing and analysis of the specimen. Consultation regarding selection, collection, transportation and result interpretation shall also be provided when required.
Response:
Responses to this Special Notice should be able to demonstrate the firm's ability, capability, and responsibility to deliver the service listed above. The purpose of this Special Notice announcement is for market research to make appropriate acquisition decisions and to gain knowledge of potential qualified Service-Disabled Veteran Owned Small Businesses, Veteran Owned Small Businesses, 8(a), HubZone and other Small Businesses interested and capable of providing the services described above. Documentation of technical expertise must be presented in sufficient detail for the Government to determine that your company possesses the necessary functional area expertise and experience to compete for this acquisition. No funds have been authorized, appropriated, or received for this effort. Responses should include the following information: Business name, address, business size and Socioeconomic Category (HUBZone, 8(a), Service-Disabled Veteran, Small Business, Large Business, etc.), and point of contact to include e-mail address and telephone number. All offerors must be registered in the System for Award Management (
www.sam.gov) and Representations and Certifications must be completed prior to any future award. Supporting evidence must be furnished in sufficient detail to demonstrate the ability to provide the full maintenance and repair service on equipment listed. Determination by the Government not to compete this proposed contract based on responses to this notice is solely within the discretion of the Government.
Important information:
The Government is not obligated to, nor will it pay for or reimburse any costs associated with responding to this sources sought synopsis request. This notice shall not be construed as a commitment by the Government to issue a solicitation or ultimately award a contract, nor does it restrict the Government to a particular acquisition approach. The Government will in no way be bound to this information if any solicitation is issued. No sub-contracting opportunity is anticipated. The North American Classification System (NAICS) code for this acquisition is 621511($36.5 Million).
Any offeror capable of providing this service shall notify the Contracting Officer by email within 14 calendar days from the date of the publication of this Special Notice.
All information is to be submitted via e-mail to: Lorraine.Hussain@va.gov
Files
| File | Type | Posted |
|---|---|---|
| 36C24226Q0004.docx | DOCX document |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Q301--FY27 (BASE+4) STAT Laboratory Testing - Syracuse (VA-27-00010334) | Veterans Integrated Service Network 2 | No set-aside | |
| Q301--NEW – STX Specialized Molecular Residual Disease Testing | Veterans Integrated Service Network 17 | No set-aside | |
| Q301--leptomeningeal and coronary research services. | Veterans Integrated Service Network 22 | No set-aside | |
| 6550--Cepheid GeneXpert Testing Supplies | Veterans Integrated Service Network 5 | No set-aside | |
| Q301--Reference Laboratory Testing | Veterans Integrated Service Network 2 | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity